查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2028 年全球細胞活力檢測市場規模、份額、行業趨勢分析報告（按產品、最終用戶、應用（幹細胞研究、藥物發現與開發、診斷學））、區域展望和預測
市場調查報告書
商品編碼
1184254

2022-2028 年全球細胞活力檢測市場規模、份額、行業趨勢分析報告（按產品、最終用戶、應用（幹細胞研究、藥物發現與開發、診斷學））、區域展望和預測

Global Cell Viability Assays Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application (Stem Cell Research, Drug Discovery & Development, and Diagnostics), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 355 Pages | 訂單完成後即時交付

價格

到 2028 年，全球細胞活力檢測市場規模預計將達到 25 億美元，在預測期內以 9.7% 的複合年增長率增長。

具有預期結果的細胞類型和數量將決定檢測方法的適當技術。 細胞增殖檢測是監測細胞分裂時間、DNA 合成、細胞數量和代謝活動的最佳選擇。 Calcein AM和台盼藍是用於細胞計數的活力染料，也可以同時獲得增殖和活力。

細胞活力測定通常涉及篩選化合物以確定測試分子是否影響細胞增殖或表現出可導致細胞死亡的直接細胞毒性作用。用於評估。 此外，細胞活力測定通常用於測量受體結合和各種信號事件，其中可能包括基因表達、細胞器功能或細胞成分的遷移。

COVID-19 影響分析

從開發和支持到藥物供應鏈規劃，生物技術和製藥公司正在與政府合作應對 COVID-19 大流行。 例如，許多常用藥物，如羥氯奎，正在經歷 COVID-19 管理需求的激增。 對這些藥物的高需求為 COVID-19 管理藥物製造商提供了巨大的機會。 此外，隨著製藥和生物技術公司的激增，對 COVID-19 疫苗和療法的需求增加預計將推動細胞活力檢測市場的發展。

市場增長因素

改善融資渠道和醫療保健行業的興起

政府對醫療保健行業投資的數量和規模不斷增加是推動市場增長的主要因素之一。 快速的經濟發展和不斷上漲的醫療保健成本將使許多發展中國家獲得一流的醫療保健系統。 從人均醫療保健支出的增加以及對高質量和負擔得起的醫療保健服務的需求增加可以推斷出每個國家醫療保健部門的快速擴張。 由於醫療保健行業的擴張和資金的增加，預計細胞活力測定的市場將會擴大。

傳染病和慢性病患者增加

由於生活方式的改變、人口老齡化、肥胖症的增加、煙草的普及和城市化，慢性病患者的數量正在增加。 據聯合國稱，五分之三的死亡與四種主要非傳染性疾病 (NCD) 有關：糖尿病、心血管疾病、慢性肺病和癌症。 非傳染性疾病負擔日益加重，尤其是在低收入國家，這使得控制和預防非傳染性疾病成為全球優先事項。 傳染病和慢性病發病率和頻率的增加正在推動細胞活力測定市場的發展。

市場約束

醫療保健專業人員短缺

衛生工作者短缺的原因是許多國家對衛生工作者的培訓和教育進行了投資。 另一個主要因素是就業和教育政策在醫療體系和人口需求方面的不匹配。 此外，在偏遠、服務欠缺的農村地區部署醫護人員的困難加劇了這種情況。 此外，衛生工作者流動性的增加可能會進一步加劇短缺，特別是在低收入和中等收入國家。

產品展望

細胞活力測定市場按產品分為耗材和設備。 由於製藥公司使用液相色譜儀、核共振 (NMR) 光譜儀和氣相色譜儀等儀器進行研發，因此它們可以顯著縮短開發和研究週期，並更快地將有益藥物推向市場。因為你正在投入。 與手動方法相比，用於分析細胞活力的儀器方法具有顯著優勢。

應用展望

細胞活力測定市場按應用細分為藥物發現和開發、幹細胞研究和診斷。 在 2021 年的細胞活力檢測市場中，藥物發現與開發領域實現了大幅增長。 這是因為細胞活力測定由於其適應性、多功能性和靈活性而在藥物開發和發現的各個階段發揮著不可或缺的作用。 細胞活力主要用於藥物發現和開發過程，以評估細胞對藥物和化合物的反應。

最終用戶視角

按最終用戶劃分，細胞活力檢測市場分為生物製藥/製藥公司、CRO/CMO、學術/研究機構和診斷實驗室。 生物製藥和製藥公司部門在 2021 年獲得了細胞活力測定市場的最高增長率。 這是由於在藥物中越來越多地使用生存力測定來評估已開發藥物的細胞效應。 研究人員使用多種細胞來確定已開發療法的功效，通常針對癌症。

區域展望

按地區劃分，分析了北美、歐洲、亞太地區和拉美地區的細胞活力檢測市場。 北美地區將在 2021 年以最大的收入份額引領細胞活力檢測市場。 該地區市場增長的原因是各種政府計劃的推出、癌症等慢性病病例的增加，以及該地區實驗室和臨床研究的高質量基礎設施的存在。 人們對使用乾細胞進行研究的興趣也越來越大，這進一步擴大了新的治療機會。

市場進入者採用的主要策略是產品發布。 根據 Cardinal Matrix 中的分析，Thermo Fisher Scientific, Inc. 是細胞活力測定市場的先驅。 Becton、Dickinson and Company、Merck KGaA 和 Bio-Rad Laboratories, Inc. 等公司是細胞活力檢測市場的領先創新者。

內容

第一章市場範圍與研究方法

  • 市場定義
  • 目的
  • 市場規模
  • 細分
    • 全球細胞活力檢測市場，按產品分類
    • 全球細胞活力檢測市場，按最終用戶分類
    • 全球細胞活力檢測市場，按應用分類
    • 全球細胞活力檢測市場，按地區
  • 調查方法

第 2 章市場概述

  • 介紹
    • 概覽
      • 市場構成和情景
  • 影響市場的主要因素
    • 市場驅動因素
    • 市場製約因素

第 3 章競爭分析 - 世界

  • KBV 基數矩陣
  • 近期的全行業戰略發展
    • 夥伴關係、協作和合同
    • 產品發布和產品擴展
    • 收購與合併
  • 關鍵成功策略
    • 主要領先戰略：比例分佈（2018-2022 年）

第 4 章全球細胞活力測定市場：按產品分類

  • 全球耗材市場：按地區
  • 全球細胞活力檢測市場（按耗材類型）
    • 按地區劃分的全球試劑和檢測試劑盒市場
    • 按試劑和檢測試劑盒類型劃分的全球試劑和檢測試劑盒市場
      • 全球發光測定市場，按地區劃分
      • 全球染料排阻分析市場，按地區
      • 全球比色測定市場，按地區劃分
      • 全球熒光測定市場：按地區
    • 全球微孔板市場：按地區
  • 全球儀器市場：按地區
  • 全球細胞活力檢測市場（按儀器類型）
    • 按地區分列的分光光度計全球市場
    • 全球顯微鏡市場：按地區
    • 全球細胞成像和分析系統市場，按地區劃分
    • 流式細胞術全球市場：按地區
    • 世界其他地區的世界市場

第 5 章全球細胞活力測定市場：按最終用戶分類

  • 全球生物製藥和製藥公司市場，按地區劃分
  • 全球 CRO/CMO 市場：按地區
  • 按地區劃分的學術和研究機構全球市場
  • 全球診斷實驗室市場，按地區

第 6 章全球細胞活力測定市場：按應用

  • 全球幹細胞研究市場：按地區
  • 藥物發現和市場開發的全球市場：按地區
  • 全球診斷市場：按地區

第 7 章。全球細胞活力檢測市場：按地區分類

  • 北美
    • 按國家/地區劃分的北美細胞活力測定市場
      • 美國
      • 加拿大
      • 墨西哥
      • 其他北美地區
  • 歐洲
    • 歐洲細胞活力檢測市場：按國家/地區分類
      • 德國
      • 英國
      • 法國
      • 俄羅斯
      • 西班牙
      • 意大利
      • 其他歐洲
  • 亞太地區
    • 按國家/地區劃分的亞太地區細胞活力測定市場
      • 中國
      • 日本
      • 印度
      • 韓國
      • 新加坡
      • 馬來西亞
      • 其他亞太地區
  • 拉美
    • LAMEA 細胞活力檢測市場：按國家/地區分類
      • 巴西
      • 阿根廷
      • 阿聯酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亞
      • 拉美其他地區

第八章公司簡介

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad laboratories, Inc.
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Merck KGaA
  • Abcam plc
  • Promega Corporation
  • Creative Bioarray
  • Biotium, Inc.

The Global Cell Viability Assays Market size is expected to reach $2.5 billion by 2028, rising at a market growth of 9.7% CAGR during the forecast period.

Cell viability is used to measure the proportion of healthy and live cells in a population, and viability assays are done after the injection of an experimental substance to check the overall health and survival rate of the cells. In addition, cell viability assays are performed to check a drug's efficiency, safety, and therapeutic abilities before it can be launched commercially in the market.

Studies related to viability are also carried out to determine the effectiveness of the cryopreservation techniques, cell culture techniques, and the toxicity of the experimental substance. The assays to measure cellular proliferation, and cytotoxicity are widely utilized to supervise the response of and health of the cultural cells when they are treated with various stimuli.

The type and number of cells with the expected result decide the proper technique for the assay method. The cell proliferation assay is the most suitable option to monitor the number of cellular divisions, DNA synthesis, number of cells, and metabolic activity. Calcein AM and trypan blue are the viability dyes used for cell counting and can also provide both the rate of proliferation and viable cell percentage.

Cell-based assays are generally used for collecting screening of compounds to evaluate if the test molecules have effects on cell proliferation or if they show direct cytotoxic impacts that may lead to cell death. In addition, cell-based assays are often used to measure the binding of receptors and various signal transduction events, which may involve the expression of genetic reporters, monitoring organelle functions, or cellular component's movement.

COVID-19 Impact Analysis

From development & support to planning the medicine supply chain, the biotech and pharmaceutical companies are working jointly with the governments to address the COVID-19 pandemic. For example, many commonly used drugs like hydroxychloroquine have seen a sharp rise in the demand for COVID-19 management. The high demand for these drugs has given enormous opportunities for manufacturers of COVID-19 management drugs. In addition, the pharmaceutical and biotechnological companies are expected to see a sharp rise due to the rising demand for vaccines and treatment drugs for novel coronavirus, which will boost the market for cell viability assays.

Market Growth Factors

Increase Access To Funding And Rise Of The Health Care Industry

The increasing amount and size of investments in the healthcare sector by the government of various countries are one of the primary factors boosting the market's growth. Due to their fast economic development and increasing healthcare cost, many developing nations will have great access to the top-notch healthcare system. The rapid increase of the healthcare sector in various countries can be assed by the rising increase in per-capita spending on healthcare and rising demand for quality and affordable healthcare services. With the rising healthcare sector and increasing funding, market for cell viability assays will propel.

Rising Cases Of Infectious And Chronic Disease

The cases of chronic diseases are increasing owing to the changing lifestyles and the increasing old age population, increasing obesity levels, easy & broad availability of tobacco, and urbanization. According to the United Nations, every three out of five deaths are related to four major non-communicable diseases (NCDs), which are diabetes, cardiovascular disease, chronic lung disease, and cancer. The management and prevention of NCDs have become a priority globally due to the rising burden of NCDs, especially in low-income countries. The growing incidences and frequency of infectious and chronic diseases are aiding the cell viability assay market to develop.

Market Restraining Factors

The Unavailability Of Healthcare Professionals

The shortage of healthcare professionals is due to the investments in the training and education of healthcare workers in many countries. Also, the mismatch in the employment and education policies concerning the healthcare system and the population requirement is a significant factor. The situation worsens due to difficulties deploying healthcare workers in remote, underserved, and rural areas. Additionally, there is an increase in the migration of health workers, which may further increase the shortage, especially in low and lower-middle-income nations.

Product Outlook

Based on the product, the cell viability assays market is segmented into consumables and instrument. Because pharmaceutical companies perform research & development with instruments like liquid chromatographers, nuclear resonance (NMR) spectrometers and gas chromatographer, which significantly increase the development and research cycles, and bring beneficial drugs to the market at a faster rate. Instrumental methods for the analysis of the cell viability gives significant advantages over manual ones.

Application Outlook

On the basis of application, the cell viability assays market is classified into drug discovery & development, stem cell research and diagnostics. The drug discovery & development segment recorded a considerable growth rate in the cell viability assays market in 2021. This is because the cell viability assay plays an essential role in various stages of drug development and discovery because of its adaptability, versatility, and flexibility. Cell viability is primarily used to assess the response of the cells against a drug or a chemical compound during the drug discovery and development process.

End User Outlook

By end user, the cell viability assays market is bifurcated into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes and Diagnostic Labs. The biopharmaceutical & pharmaceutical companies segment procured the highest growth rate in the cell viability assays market in 2021. This is attributable from the increasing usage of viability assays in pharmaceuticals to assess the influence of the developed agents' cells. Researchers employ various cells to determine the effect of the developed treatment, which often targets cancer tumors..

Regional Outlook

Region-wise, the cell viability assays market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region led the cell viability assays market by generating maximum revenue share in 2021. The market is expanding in this region because of the introduction of various government schemes, the rising cases of chronic diseases like cancer, and the presence of high-quality infrastructure for laboratory and clinical research in the region. There is also a lean towards stem cell-based research, which further opens new treatment opportunities.

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Thermo Fisher Scientific, Inc. is the forerunner in the Cell Viability Assays Market. Companies such as Becton, Dickinson and Company, Merck KGaA, Bio-Rad Laboratories, Inc. are some of the key innovators in Cell Viability Assays Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.

Recent Strategies Deployed in Cell Viability Assays Market

Product Launches and Expansions:

Sep-2022: PerkinElmer, Inc. unveiled Cellaca PLX Image Cytometry System, a platform that enables researchers to test Critical Quality Attributes of cell samples in a single automated workflow. Through this launch, PerkinElmer would benefit researchers working in the field of CAR-T cell therapy and required to design phenotyping of immune cells for downstream processes.

Aug-2022: Thermo Fisher Scientific released Enhanced Applied Biosystems HIV-1 Genotyping Kit. The newly launched kit aligns with the previously launched Applied Biosystems MagMAX Viral/Pathogen Nucleic Acid Isolation Kit for HIV-1 Blood Spots. The product helps labs with an advanced tool for drug resistance surveillance of HIV mutations to antiretroviral therapeutic inhibitors.

Mar-2022: Thermo Fisher released Gibco CTS Xenon Electroporation System, an electroporation system for cell therapy development. The product allows gene modification without utilizing traditional viral vectors.

Mar-2022: BD unveiled the BD Rhapsody TCR/BCR Multiomic Assay, a range of reagents. Through this launch, the company aimed to offer a solution to researchers to simply as well as comprehensively evaluate key cells within the immune system. Moreover, it would help in the advancement of immuno-oncology, autoimmune disorders, and infectious diseases.

Aug-2021: BD released BD COR PX/GX System, a fully automated high-throughput diagnostic system. Through this launch, the company aimed to redefine the concept of automation in molecular testing of infectious diseases throughout key laboratories as well as other centralized laboratories across the United States.

Aug-2020: Promega launched the Promega Limit Dx SARS-CoV-2 Immunoassay, a serological antibody test for COVID-19. This in vitro diagnostic test aimed to offer a PPA sensitivity of 93.5% while being utilized and evaluated with samples from patients with diverse disease levels as well as 100% sensitivity within hospitalized patients.

Acquisitions and Mergers:

Feb-2022: BD took over Cytognos, a Biotech company. Through this acquisition, the company aimed to expedite the strategy of BD to help in the management of chronic diseases by expanding its offerings, which include immune assessment tests, blood cancer diagnostics, and informatics with the aim to address the demands of clinicians, patients, and care providers.

May-2021: PerkinElmer took over Nexcelom Bioscience, a Massachusetts-based biotechnology company. Under this acquisition, the integration would broaden PerkinElmer's efforts to support the government, academic, and biopharmaceutical organizations in developing their comprehensive workflows and help efforts to boost time to market and time to target other beneficial therapies.

Feb-2021: Thermo Fisher Scientific took over Cell Sorting Technology from Propel Labs, a biotechnology instrumentation company. Through this acquisition, Thermo Fisher strengthens its cell therapy research and cell analysis business with the flow cytometry expertise of Propel Labs, engineering strength, and R&D abilities.

Apr-2020: Bio-Rad Laboratories took over Celsee, an instruments and consumables provider. With this acquisition, the company aimed to expand its reach throughout the world in order to meet the rising demands of customers for single-cell analysis and precision medicine in order to offer improved insight into the disease along with its diagnosis as well as treatment.

Partnerships, Collaborations and Agreements:

Mar-2022: Promega came into an agreement with FUJIFILM Cellular Dynamics, a leader in providing human iPSC technologies. Under this agreement, the companies aimed to expedite the development of a new assay for drug discovery.

Nov-2021: Thermo Fisher entered into an agreement with Cellenion, a BICO company. Through this agreement, the companies aimed to accelerate single-cell proteomics analyses with the integration of Cellenion's proteoCHIPTM and cellenONE into TMT multiplexing technologies and Orbitrap Orbitrap mass spectrometers of Thermo Fisher. In addition, this integration would allow the companies to offer complete solutions ranging from automated sample preparation and single-cell isolation to mass spectrometry)-based proteomics analysis on single cells.

Jun-2021: Bio-Rad Laboratories agreed with Seegene, a leading biotechnology business. Following this agreement, Bio-Rad aimed to leverage the capabilities of Seegene to accelerate its penetration within the United States market by receiving FDA approvals for its clinical assays.

Geographical Expansions:

Jun-2021: Bio-Rad Laboratories agreed with Seegene, a leading biotechnology business. Following this agreement, Bio-Rad aimed to leverage the capabilities of Seegene to accelerate its penetration within the United States market by receiving FDA approvals for its clinical assays.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Consumables
    • Reagents & Assay Kits
  • Luminometric Assays
  • Dye Exclusion Assays
  • Colorimetric Assays
  • Fluorometric Assays
    • Microplates
  • Instruments
    • Spectrophotometer
    • Microscopy
    • Cell Imaging & Analysis System
    • Flow Cytometry
    • Others

By End User

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes
  • Diagnostic Labs

By Application

  • Stem Cell Research
  • Drug Discovery & Development
  • Diagnostics

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • PerkinElmer Inc.
  • Promega Corporation
  • Biotium
  • Creative Bioarray
  • Abcam Plc

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Cell Viability Assays Market, by Product
    • 1.4.2 Global Cell Viability Assays Market, by End User
    • 1.4.3 Global Cell Viability Assays Market, by Application
    • 1.4.4 Global Cell Viability Assays Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market composition and Scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Cell Viability Assays Market by Product

  • 4.1 Global Consumables Market by Region
  • 4.2 Global Cell Viability Assays Market by Consumables Type
    • 4.2.1 Global Reagents & Assay Kits Market by Region
    • 4.2.2 Global Cell Viability Assays Market by Reagents & Assay Kits Type
      • 4.2.2.1 Global Luminometric Assays Market by Region
      • 4.2.2.2 Global Dye Exclusion Assays Market by Region
      • 4.2.2.3 Global Colorimetric Assays Market by Region
      • 4.2.2.4 Global Fluorometric Assays Market by Region
    • 4.2.3 Global Microplates Market by Region
  • 4.3 Global Instruments Market by Region
  • 4.4 Global Cell Viability Assays Market by Instruments Type
    • 4.4.1 Global Spectrophotometer Market by Region
    • 4.4.2 Global Microscopy Market by Region
    • 4.4.3 Global Cell Imaging & Analysis System Market by Region
    • 4.4.4 Global Flow Cytometry Market by Region
    • 4.4.5 Global Others Market by Region

Chapter 5. Global Cell Viability Assays Market by End-user

  • 5.1 Global Biopharmaceutical & Pharmaceutical Companies Market by Region
  • 5.2 Global CROs & CMOs Market by Region
  • 5.3 Global Academic & Research Institutes Market by Region
  • 5.4 Global Diagnostic Labs Market by Region

Chapter 6. Global Cell Viability Assays Market by Application

  • 6.1 Global Stem Cell Research Market by Region
  • 6.2 Global Drug Discovery & Development Market by Region
  • 6.3 Global Diagnostics Market by Region

Chapter 7. Global Cell Viability Assays Market by Region

  • 7.1 North America Cell Viability Assays Market
    • 7.1.1 North America Cell Viability Assays Market by Product
      • 7.1.1.1 North America Consumables Market by Country
      • 7.1.1.2 North America Cell Viability Assays Market by Consumables Type
        • 7.1.1.2.1 North America Reagents & Assay Kits Market by Country
        • 7.1.1.2.2 North America Cell Viability Assays Market by Reagents & Assay Kits Type
          • 7.1.1.2.2.1 North America Luminometric Assays Market by Country
          • 7.1.1.2.2.2 North America Dye Exclusion Assays Market by Country
          • 7.1.1.2.2.3 North America Colorimetric Assays Market by Country
          • 7.1.1.2.2.4 North America Fluorometric Assays Market by Country
        • 7.1.1.2.3 North America Microplates Market by Country
      • 7.1.1.3 North America Instruments Market by Country
      • 7.1.1.4 North America Cell Viability Assays Market by Instruments Type
        • 7.1.1.4.1 North America Spectrophotometer Market by Country
        • 7.1.1.4.2 North America Microscopy Market by Country
        • 7.1.1.4.3 North America Cell Imaging & Analysis System Market by Country
        • 7.1.1.4.4 North America Flow Cytometry Market by Country
        • 7.1.1.4.5 North America Others Market by Country
    • 7.1.2 North America Cell Viability Assays Market by End-user
      • 7.1.2.1 North America Biopharmaceutical & Pharmaceutical Companies Market by Country
      • 7.1.2.2 North America CROs & CMOs Market by Country
      • 7.1.2.3 North America Academic & Research Institutes Market by Country
      • 7.1.2.4 North America Diagnostic Labs Market by Country
    • 7.1.3 North America Cell Viability Assays Market by Application
      • 7.1.3.1 North America Stem Cell Research Market by Country
      • 7.1.3.2 North America Drug Discovery & Development Market by Country
      • 7.1.3.3 North America Diagnostics Market by Country
    • 7.1.4 North America Cell Viability Assays Market by Country
      • 7.1.4.1 US Cell Viability Assays Market
        • 7.1.4.1.1 US Cell Viability Assays Market by Product
          • 7.1.4.1.1.1 US Cell Viability Assays Market by Consumables Type
          • 7.1.4.1.1.2 US Cell Viability Assays Market by Instruments Type
        • 7.1.4.1.2 US Cell Viability Assays Market by End-user
        • 7.1.4.1.3 US Cell Viability Assays Market by Application
      • 7.1.4.2 Canada Cell Viability Assays Market
        • 7.1.4.2.1 Canada Cell Viability Assays Market by Product
          • 7.1.4.2.1.1 Canada Cell Viability Assays Market by Consumables Type
          • 7.1.4.2.1.2 Canada Cell Viability Assays Market by Instruments Type
        • 7.1.4.2.2 Canada Cell Viability Assays Market by End-user
        • 7.1.4.2.3 Canada Cell Viability Assays Market by Application
      • 7.1.4.3 Mexico Cell Viability Assays Market
        • 7.1.4.3.1 Mexico Cell Viability Assays Market by Product
          • 7.1.4.3.1.1 Mexico Cell Viability Assays Market by Consumables Type
          • 7.1.4.3.1.2 Mexico Cell Viability Assays Market by Instruments Type
        • 7.1.4.3.2 Mexico Cell Viability Assays Market by End-user
        • 7.1.4.3.3 Mexico Cell Viability Assays Market by Application
      • 7.1.4.4 Rest of North America Cell Viability Assays Market
        • 7.1.4.4.1 Rest of North America Cell Viability Assays Market by Product
          • 7.1.4.4.1.1 Rest of North America Cell Viability Assays Market by Consumables Type
          • 7.1.4.4.1.2 Rest of North America Cell Viability Assays Market by Instruments Type
        • 7.1.4.4.2 Rest of North America Cell Viability Assays Market by End-user
        • 7.1.4.4.3 Rest of North America Cell Viability Assays Market by Application
  • 7.2 Europe Cell Viability Assays Market
    • 7.2.1 Europe Cell Viability Assays Market by Product
      • 7.2.1.1 Europe Consumables Market by Country
      • 7.2.1.2 Europe Cell Viability Assays Market by Consumables Type
        • 7.2.1.2.1 Europe Reagents & Assay Kits Market by Country
        • 7.2.1.2.2 Europe Cell Viability Assays Market by Reagents & Assay Kits Type
          • 7.2.1.2.2.1 Europe Luminometric Assays Market by Country
          • 7.2.1.2.2.2 Europe Dye Exclusion Assays Market by Country
          • 7.2.1.2.2.3 Europe Colorimetric Assays Market by Country
          • 7.2.1.2.2.4 Europe Fluorometric Assays Market by Country
        • 7.2.1.2.3 Europe Microplates Market by Country
      • 7.2.1.3 Europe Instruments Market by Country
      • 7.2.1.4 Europe Cell Viability Assays Market by Instruments Type
        • 7.2.1.4.1 Europe Spectrophotometer Market by Country
        • 7.2.1.4.2 Europe Microscopy Market by Country
        • 7.2.1.4.3 Europe Cell Imaging & Analysis System Market by Country
        • 7.2.1.4.4 Europe Flow Cytometry Market by Country
        • 7.2.1.4.5 Europe Others Market by Country
    • 7.2.2 Europe Cell Viability Assays Market by End-user
      • 7.2.2.1 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country
      • 7.2.2.2 Europe CROs & CMOs Market by Country
      • 7.2.2.3 Europe Academic & Research Institutes Market by Country
      • 7.2.2.4 Europe Diagnostic Labs Market by Country
    • 7.2.3 Europe Cell Viability Assays Market by Application
      • 7.2.3.1 Europe Stem Cell Research Market by Country
      • 7.2.3.2 Europe Drug Discovery & Development Market by Country
      • 7.2.3.3 Europe Diagnostics Market by Country
    • 7.2.4 Europe Cell Viability Assays Market by Country
      • 7.2.4.1 Germany Cell Viability Assays Market
        • 7.2.4.1.1 Germany Cell Viability Assays Market by Product
          • 7.2.4.1.1.1 Germany Cell Viability Assays Market by Consumables Type
          • 7.2.4.1.1.2 Germany Cell Viability Assays Market by Instruments Type
        • 7.2.4.1.2 Germany Cell Viability Assays Market by End-user
        • 7.2.4.1.3 Germany Cell Viability Assays Market by Application
      • 7.2.4.2 UK Cell Viability Assays Market
        • 7.2.4.2.1 UK Cell Viability Assays Market by Product
          • 7.2.4.2.1.1 UK Cell Viability Assays Market by Consumables Type
          • 7.2.4.2.1.2 UK Cell Viability Assays Market by Instruments Type
        • 7.2.4.2.2 UK Cell Viability Assays Market by End-user
        • 7.2.4.2.3 UK Cell Viability Assays Market by Application
      • 7.2.4.3 France Cell Viability Assays Market
        • 7.2.4.3.1 France Cell Viability Assays Market by Product
          • 7.2.4.3.1.1 France Cell Viability Assays Market by Consumables Type
          • 7.2.4.3.1.2 France Cell Viability Assays Market by Instruments Type
        • 7.2.4.3.2 France Cell Viability Assays Market by End-user
        • 7.2.4.3.3 France Cell Viability Assays Market by Application
      • 7.2.4.4 Russia Cell Viability Assays Market
        • 7.2.4.4.1 Russia Cell Viability Assays Market by Product
          • 7.2.4.4.1.1 Russia Cell Viability Assays Market by Consumables Type
          • 7.2.4.4.1.2 Russia Cell Viability Assays Market by Instruments Type
        • 7.2.4.4.2 Russia Cell Viability Assays Market by End-user
        • 7.2.4.4.3 Russia Cell Viability Assays Market by Application
      • 7.2.4.5 Spain Cell Viability Assays Market
        • 7.2.4.5.1 Spain Cell Viability Assays Market by Product
          • 7.2.4.5.1.1 Spain Cell Viability Assays Market by Consumables Type
          • 7.2.4.5.1.2 Spain Cell Viability Assays Market by Instruments Type
        • 7.2.4.5.2 Spain Cell Viability Assays Market by End-user
        • 7.2.4.5.3 Spain Cell Viability Assays Market by Application
      • 7.2.4.6 Italy Cell Viability Assays Market
        • 7.2.4.6.1 Italy Cell Viability Assays Market by Product
          • 7.2.4.6.1.1 Italy Cell Viability Assays Market by Consumables Type
          • 7.2.4.6.1.2 Italy Cell Viability Assays Market by Instruments Type
        • 7.2.4.6.2 Italy Cell Viability Assays Market by End-user
        • 7.2.4.6.3 Italy Cell Viability Assays Market by Application
      • 7.2.4.7 Rest of Europe Cell Viability Assays Market
        • 7.2.4.7.1 Rest of Europe Cell Viability Assays Market by Product
          • 7.2.4.7.1.1 Rest of Europe Cell Viability Assays Market by Consumables Type
          • 7.2.4.7.1.2 Rest of Europe Cell Viability Assays Market by Instruments Type
        • 7.2.4.7.2 Rest of Europe Cell Viability Assays Market by End-user
        • 7.2.4.7.3 Rest of Europe Cell Viability Assays Market by Application
  • 7.3 Asia Pacific Cell Viability Assays Market
    • 7.3.1 Asia Pacific Cell Viability Assays Market by Product
      • 7.3.1.1 Asia Pacific Consumables Market by Country
      • 7.3.1.2 Asia Pacific Cell Viability Assays Market by Consumables Type
        • 7.3.1.2.1 Asia Pacific Reagents & Assay Kits Market by Country
        • 7.3.1.2.2 Asia Pacific Cell Viability Assays Market by Reagents & Assay Kits Type
          • 7.3.1.2.2.1 Asia Pacific Luminometric Assays Market by Country
          • 7.3.1.2.2.2 Asia Pacific Dye Exclusion Assays Market by Country
          • 7.3.1.2.2.3 Asia Pacific Colorimetric Assays Market by Country
          • 7.3.1.2.2.4 Asia Pacific Fluorometric Assays Market by Country
        • 7.3.1.2.3 Asia Pacific Microplates Market by Country
      • 7.3.1.3 Asia Pacific Instruments Market by Country
      • 7.3.1.4 Asia Pacific Cell Viability Assays Market by Instruments Type
        • 7.3.1.4.1 Asia Pacific Spectrophotometer Market by Country
        • 7.3.1.4.2 Asia Pacific Microscopy Market by Country
        • 7.3.1.4.3 Asia Pacific Cell Imaging & Analysis System Market by Country
        • 7.3.1.4.4 Asia Pacific Flow Cytometry Market by Country
        • 7.3.1.4.5 Asia Pacific Others Market by Country
    • 7.3.2 Asia Pacific Cell Viability Assays Market by End-user
      • 7.3.2.1 Asia Pacific Biopharmaceutical & Pharmaceutical Companies Market by Country
      • 7.3.2.2 Asia Pacific CROs & CMOs Market by Country
      • 7.3.2.3 Asia Pacific Academic & Research Institutes Market by Country
      • 7.3.2.4 Asia Pacific Diagnostic Labs Market by Country
    • 7.3.3 Asia Pacific Cell Viability Assays Market by Application
      • 7.3.3.1 Asia Pacific Stem Cell Research Market by Country
      • 7.3.3.2 Asia Pacific Drug Discovery & Development Market by Country
      • 7.3.3.3 Asia Pacific Diagnostics Market by Country
    • 7.3.4 Asia Pacific Cell Viability Assays Market by Country
      • 7.3.4.1 China Cell Viability Assays Market
        • 7.3.4.1.1 China Cell Viability Assays Market by Product
          • 7.3.4.1.1.1 China Cell Viability Assays Market by Consumables Type
          • 7.3.4.1.1.2 China Cell Viability Assays Market by Instruments Type
        • 7.3.4.1.2 China Cell Viability Assays Market by End-user
        • 7.3.4.1.3 China Cell Viability Assays Market by Application
      • 7.3.4.2 Japan Cell Viability Assays Market
        • 7.3.4.2.1 Japan Cell Viability Assays Market by Product
          • 7.3.4.2.1.1 Japan Cell Viability Assays Market by Consumables Type
          • 7.3.4.2.1.2 Japan Cell Viability Assays Market by Instruments Type
        • 7.3.4.2.2 Japan Cell Viability Assays Market by End-user
        • 7.3.4.2.3 Japan Cell Viability Assays Market by Application
      • 7.3.4.3 India Cell Viability Assays Market
        • 7.3.4.3.1 India Cell Viability Assays Market by Product
          • 7.3.4.3.1.1 India Cell Viability Assays Market by Consumables Type
          • 7.3.4.3.1.2 India Cell Viability Assays Market by Instruments Type
        • 7.3.4.3.2 India Cell Viability Assays Market by End-user
        • 7.3.4.3.3 India Cell Viability Assays Market by Application
      • 7.3.4.4 South Korea Cell Viability Assays Market
        • 7.3.4.4.1 South Korea Cell Viability Assays Market by Product
          • 7.3.4.4.1.1 South Korea Cell Viability Assays Market by Consumables Type
          • 7.3.4.4.1.2 South Korea Cell Viability Assays Market by Instruments Type
        • 7.3.4.4.2 South Korea Cell Viability Assays Market by End-user
        • 7.3.4.4.3 South Korea Cell Viability Assays Market by Application
      • 7.3.4.5 Singapore Cell Viability Assays Market
        • 7.3.4.5.1 Singapore Cell Viability Assays Market by Product
          • 7.3.4.5.1.1 Singapore Cell Viability Assays Market by Consumables Type
          • 7.3.4.5.1.2 Singapore Cell Viability Assays Market by Instruments Type
        • 7.3.4.5.2 Singapore Cell Viability Assays Market by End-user
        • 7.3.4.5.3 Singapore Cell Viability Assays Market by Application
      • 7.3.4.6 Malaysia Cell Viability Assays Market
        • 7.3.4.6.1 Malaysia Cell Viability Assays Market by Product
          • 7.3.4.6.1.1 Malaysia Cell Viability Assays Market by Consumables Type
          • 7.3.4.6.1.2 Malaysia Cell Viability Assays Market by Instruments Type
        • 7.3.4.6.2 Malaysia Cell Viability Assays Market by End-user
        • 7.3.4.6.3 Malaysia Cell Viability Assays Market by Application
      • 7.3.4.7 Rest of Asia Pacific Cell Viability Assays Market
        • 7.3.4.7.1 Rest of Asia Pacific Cell Viability Assays Market by Product
          • 7.3.4.7.1.1 Rest of Asia Pacific Cell Viability Assays Market by Consumables Type
          • 7.3.4.7.1.2 Rest of Asia Pacific Cell Viability Assays Market by Instruments Type
        • 7.3.4.7.2 Rest of Asia Pacific Cell Viability Assays Market by End-user
        • 7.3.4.7.3 Rest of Asia Pacific Cell Viability Assays Market by Application
  • 7.4 LAMEA Cell Viability Assays Market
    • 7.4.1 LAMEA Cell Viability Assays Market by Product
      • 7.4.1.1 LAMEA Consumables Market by Country
      • 7.4.1.2 LAMEA Cell Viability Assays Market by Consumables Type
        • 7.4.1.2.1 LAMEA Reagents & Assay Kits Market by Country
        • 7.4.1.2.2 LAMEA Cell Viability Assays Market by Reagents & Assay Kits Type
          • 7.4.1.2.2.1 LAMEA Luminometric Assays Market by Country
          • 7.4.1.2.2.2 LAMEA Dye Exclusion Assays Market by Country
          • 7.4.1.2.2.3 LAMEA Colorimetric Assays Market by Country
          • 7.4.1.2.2.4 LAMEA Fluorometric Assays Market by Country
        • 7.4.1.2.3 LAMEA Microplates Market by Country
      • 7.4.1.3 LAMEA Instruments Market by Country
      • 7.4.1.4 LAMEA Cell Viability Assays Market by Instruments Type
        • 7.4.1.4.1 LAMEA Spectrophotometer Market by Country
        • 7.4.1.4.2 LAMEA Microscopy Market by Country
        • 7.4.1.4.3 LAMEA Cell Imaging & Analysis System Market by Country
        • 7.4.1.4.4 LAMEA Flow Cytometry Market by Country
        • 7.4.1.4.5 LAMEA Others Market by Country
    • 7.4.2 LAMEA Cell Viability Assays Market by End-user
      • 7.4.2.1 LAMEA Biopharmaceutical & Pharmaceutical Companies Market by Country
      • 7.4.2.2 LAMEA CROs & CMOs Market by Country
      • 7.4.2.3 LAMEA Academic & Research Institutes Market by Country
      • 7.4.2.4 LAMEA Diagnostic Labs Market by Country
    • 7.4.3 LAMEA Cell Viability Assays Market by Application
      • 7.4.3.1 LAMEA Stem Cell Research Market by Country
      • 7.4.3.2 LAMEA Drug Discovery & Development Market by Country
      • 7.4.3.3 LAMEA Diagnostics Market by Country
    • 7.4.4 LAMEA Cell Viability Assays Market by Country
      • 7.4.4.1 Brazil Cell Viability Assays Market
        • 7.4.4.1.1 Brazil Cell Viability Assays Market by Product
          • 7.4.4.1.1.1 Brazil Cell Viability Assays Market by Consumables Type
          • 7.4.4.1.1.2 Brazil Cell Viability Assays Market by Instruments Type
        • 7.4.4.1.2 Brazil Cell Viability Assays Market by End-user
        • 7.4.4.1.3 Brazil Cell Viability Assays Market by Application
      • 7.4.4.2 Argentina Cell Viability Assays Market
        • 7.4.4.2.1 Argentina Cell Viability Assays Market by Product
          • 7.4.4.2.1.1 Argentina Cell Viability Assays Market by Consumables Type
          • 7.4.4.2.1.2 Argentina Cell Viability Assays Market by Instruments Type
        • 7.4.4.2.2 Argentina Cell Viability Assays Market by End-user
        • 7.4.4.2.3 Argentina Cell Viability Assays Market by Application
      • 7.4.4.3 UAE Cell Viability Assays Market
        • 7.4.4.3.1 UAE Cell Viability Assays Market by Product
          • 7.4.4.3.1.1 UAE Cell Viability Assays Market by Consumables Type
          • 7.4.4.3.1.2 UAE Cell Viability Assays Market by Instruments Type
        • 7.4.4.3.2 UAE Cell Viability Assays Market by End-user
        • 7.4.4.3.3 UAE Cell Viability Assays Market by Application
      • 7.4.4.4 Saudi Arabia Cell Viability Assays Market
        • 7.4.4.4.1 Saudi Arabia Cell Viability Assays Market by Product
          • 7.4.4.4.1.1 Saudi Arabia Cell Viability Assays Market by Consumables Type
          • 7.4.4.4.1.2 Saudi Arabia Cell Viability Assays Market by Instruments Type
        • 7.4.4.4.2 Saudi Arabia Cell Viability Assays Market by End-user
        • 7.4.4.4.3 Saudi Arabia Cell Viability Assays Market by Application
      • 7.4.4.5 South Africa Cell Viability Assays Market
        • 7.4.4.5.1 South Africa Cell Viability Assays Market by Product
          • 7.4.4.5.1.1 South Africa Cell Viability Assays Market by Consumables Type
          • 7.4.4.5.1.2 South Africa Cell Viability Assays Market by Instruments Type
        • 7.4.4.5.2 South Africa Cell Viability Assays Market by End-user
        • 7.4.4.5.3 South Africa Cell Viability Assays Market by Application
      • 7.4.4.6 Nigeria Cell Viability Assays Market
        • 7.4.4.6.1 Nigeria Cell Viability Assays Market by Product
          • 7.4.4.6.1.1 Nigeria Cell Viability Assays Market by Consumables Type
          • 7.4.4.6.1.2 Nigeria Cell Viability Assays Market by Instruments Type
        • 7.4.4.6.2 Nigeria Cell Viability Assays Market by End-user
        • 7.4.4.6.3 Nigeria Cell Viability Assays Market by Application
      • 7.4.4.7 Rest of LAMEA Cell Viability Assays Market
        • 7.4.4.7.1 Rest of LAMEA Cell Viability Assays Market by Product
          • 7.4.4.7.1.1 Rest of LAMEA Cell Viability Assays Market by Consumables Type
          • 7.4.4.7.1.2 Rest of LAMEA Cell Viability Assays Market by Instruments Type
        • 7.4.4.7.2 Rest of LAMEA Cell Viability Assays Market by End-user
        • 7.4.4.7.3 Rest of LAMEA Cell Viability Assays Market by Application

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Partnerships, Collaborations, and Agreements:
      • 8.1.5.2 Product Launches and Product Expansions:
      • 8.1.5.3 Acquisition and Mergers:
      • 8.1.5.4 Geographical Expansions:
  • 8.2 Agilent Technologies, Inc.
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
  • 8.3 Bio-Rad laboratories, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
  • 8.4 Becton, Dickinson and Company
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Product Launches and Product Expansions:
      • 8.4.5.2 Acquisition and Mergers:
  • 8.5 PerkinElmer, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Product Launches and Product Expansions:
      • 8.5.5.2 Acquisition and Mergers:
  • 8.6 Merck KGaA
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 Abcam plc
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
  • 8.8 Promega Corporation
    • 8.8.1 Company Overview
    • 8.8.2 Recent strategies and developments:
      • 8.8.2.1 Partnerships, Collaborations, and Agreements:
      • 8.8.2.2 Product Launches and Product Expansions:
  • 8.9 Creative Bioarray
    • 8.9.1 Company Overview
  • 8.10. Biotium, Inc.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Global Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 2 Global Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Cell Viability Assays Market
  • TABLE 4 Product Launches And Product Expansions- Cell Viability Assays Market
  • TABLE 5 Acquisition and Mergers- Cell Viability Assays Market
  • TABLE 6 Global Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 7 Global Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 8 Global Consumables Market by Region, 2018 - 2021, USD Million
  • TABLE 9 Global Consumables Market by Region, 2022 - 2028, USD Million
  • TABLE 10 Global Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 11 Global Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 12 Global Reagents & Assay Kits Market by Region, 2018 - 2021, USD Million
  • TABLE 13 Global Reagents & Assay Kits Market by Region, 2022 - 2028, USD Million
  • TABLE 14 Global Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 15 Global Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 16 Global Luminometric Assays Market by Region, 2018 - 2021, USD Million
  • TABLE 17 Global Luminometric Assays Market by Region, 2022 - 2028, USD Million
  • TABLE 18 Global Dye Exclusion Assays Market by Region, 2018 - 2021, USD Million
  • TABLE 19 Global Dye Exclusion Assays Market by Region, 2022 - 2028, USD Million
  • TABLE 20 Global Colorimetric Assays Market by Region, 2018 - 2021, USD Million
  • TABLE 21 Global Colorimetric Assays Market by Region, 2022 - 2028, USD Million
  • TABLE 22 Global Fluorometric Assays Market by Region, 2018 - 2021, USD Million
  • TABLE 23 Global Fluorometric Assays Market by Region, 2022 - 2028, USD Million
  • TABLE 24 Global Microplates Market by Region, 2018 - 2021, USD Million
  • TABLE 25 Global Microplates Market by Region, 2022 - 2028, USD Million
  • TABLE 26 Global Instruments Market by Region, 2018 - 2021, USD Million
  • TABLE 27 Global Instruments Market by Region, 2022 - 2028, USD Million
  • TABLE 28 Global Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 29 Global Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 30 Global Spectrophotometer Market by Region, 2018 - 2021, USD Million
  • TABLE 31 Global Spectrophotometer Market by Region, 2022 - 2028, USD Million
  • TABLE 32 Global Microscopy Market by Region, 2018 - 2021, USD Million
  • TABLE 33 Global Microscopy Market by Region, 2022 - 2028, USD Million
  • TABLE 34 Global Cell Imaging & Analysis System Market by Region, 2018 - 2021, USD Million
  • TABLE 35 Global Cell Imaging & Analysis System Market by Region, 2022 - 2028, USD Million
  • TABLE 36 Global Flow Cytometry Market by Region, 2018 - 2021, USD Million
  • TABLE 37 Global Flow Cytometry Market by Region, 2022 - 2028, USD Million
  • TABLE 38 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 39 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 40 Global Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 41 Global Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 42 Global Biopharmaceutical & Pharmaceutical Companies Market by Region, 2018 - 2021, USD Million
  • TABLE 43 Global Biopharmaceutical & Pharmaceutical Companies Market by Region, 2022 - 2028, USD Million
  • TABLE 44 Global CROs & CMOs Market by Region, 2018 - 2021, USD Million
  • TABLE 45 Global CROs & CMOs Market by Region, 2022 - 2028, USD Million
  • TABLE 46 Global Academic & Research Institutes Market by Region, 2018 - 2021, USD Million
  • TABLE 47 Global Academic & Research Institutes Market by Region, 2022 - 2028, USD Million
  • TABLE 48 Global Diagnostic Labs Market by Region, 2018 - 2021, USD Million
  • TABLE 49 Global Diagnostic Labs Market by Region, 2022 - 2028, USD Million
  • TABLE 50 Global Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 51 Global Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 52 Global Stem Cell Research Market by Region, 2018 - 2021, USD Million
  • TABLE 53 Global Stem Cell Research Market by Region, 2022 - 2028, USD Million
  • TABLE 54 Global Drug Discovery & Development Market by Region, 2018 - 2021, USD Million
  • TABLE 55 Global Drug Discovery & Development Market by Region, 2022 - 2028, USD Million
  • TABLE 56 Global Diagnostics Market by Region, 2018 - 2021, USD Million
  • TABLE 57 Global Diagnostics Market by Region, 2022 - 2028, USD Million
  • TABLE 58 Global Cell Viability Assays Market by Region, 2018 - 2021, USD Million
  • TABLE 59 Global Cell Viability Assays Market by Region, 2022 - 2028, USD Million
  • TABLE 60 North America Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 61 North America Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 62 North America Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 63 North America Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 64 North America Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 65 North America Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 66 North America Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 67 North America Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 68 North America Reagents & Assay Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 69 North America Reagents & Assay Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 70 North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 71 North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 72 North America Luminometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 73 North America Luminometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 74 North America Dye Exclusion Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 75 North America Dye Exclusion Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 76 North America Colorimetric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 77 North America Colorimetric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 78 North America Fluorometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 79 North America Fluorometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 80 North America Microplates Market by Country, 2018 - 2021, USD Million
  • TABLE 81 North America Microplates Market by Country, 2022 - 2028, USD Million
  • TABLE 82 North America Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 83 North America Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 84 North America Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 85 North America Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 86 North America Spectrophotometer Market by Country, 2018 - 2021, USD Million
  • TABLE 87 North America Spectrophotometer Market by Country, 2022 - 2028, USD Million
  • TABLE 88 North America Microscopy Market by Country, 2018 - 2021, USD Million
  • TABLE 89 North America Microscopy Market by Country, 2022 - 2028, USD Million
  • TABLE 90 North America Cell Imaging & Analysis System Market by Country, 2018 - 2021, USD Million
  • TABLE 91 North America Cell Imaging & Analysis System Market by Country, 2022 - 2028, USD Million
  • TABLE 92 North America Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 93 North America Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 94 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 95 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 96 North America Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 97 North America Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 98 North America Biopharmaceutical & Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 99 North America Biopharmaceutical & Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 100 North America CROs & CMOs Market by Country, 2018 - 2021, USD Million
  • TABLE 101 North America CROs & CMOs Market by Country, 2022 - 2028, USD Million
  • TABLE 102 North America Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 103 North America Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 104 North America Diagnostic Labs Market by Country, 2018 - 2021, USD Million
  • TABLE 105 North America Diagnostic Labs Market by Country, 2022 - 2028, USD Million
  • TABLE 106 North America Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 107 North America Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 108 North America Stem Cell Research Market by Country, 2018 - 2021, USD Million
  • TABLE 109 North America Stem Cell Research Market by Country, 2022 - 2028, USD Million
  • TABLE 110 North America Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 111 North America Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 112 North America Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 113 North America Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 114 North America Cell Viability Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 115 North America Cell Viability Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 116 US Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 117 US Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 118 US Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 119 US Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 120 US Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 121 US Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 122 US Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 123 US Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 124 US Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 125 US Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 126 US Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 127 US Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 128 US Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 129 US Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 130 Canada Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 131 Canada Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 132 Canada Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 133 Canada Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 134 Canada Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 135 Canada Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 136 Canada Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 137 Canada Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 138 Canada Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 139 Canada Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 140 Canada Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 141 Canada Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 142 Canada Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 143 Canada Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 144 Mexico Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 145 Mexico Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 146 Mexico Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 147 Mexico Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 148 Mexico Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 149 Mexico Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 150 Mexico Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 151 Mexico Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 152 Mexico Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 153 Mexico Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 154 Mexico Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 155 Mexico Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 156 Mexico Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 157 Mexico Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 158 Rest of North America Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 159 Rest of North America Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 160 Rest of North America Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 161 Rest of North America Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 162 Rest of North America Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 163 Rest of North America Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 164 Rest of North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 165 Rest of North America Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 166 Rest of North America Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 167 Rest of North America Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 168 Rest of North America Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 169 Rest of North America Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 170 Rest of North America Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 171 Rest of North America Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 172 Europe Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 173 Europe Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 174 Europe Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 175 Europe Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 176 Europe Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 177 Europe Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 178 Europe Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 179 Europe Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 180 Europe Reagents & Assay Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 181 Europe Reagents & Assay Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 182 Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 183 Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 184 Europe Luminometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 185 Europe Luminometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 186 Europe Dye Exclusion Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 187 Europe Dye Exclusion Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 188 Europe Colorimetric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 189 Europe Colorimetric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 190 Europe Fluorometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 191 Europe Fluorometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 192 Europe Microplates Market by Country, 2018 - 2021, USD Million
  • TABLE 193 Europe Microplates Market by Country, 2022 - 2028, USD Million
  • TABLE 194 Europe Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 195 Europe Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 196 Europe Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 197 Europe Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 198 Europe Spectrophotometer Market by Country, 2018 - 2021, USD Million
  • TABLE 199 Europe Spectrophotometer Market by Country, 2022 - 2028, USD Million
  • TABLE 200 Europe Microscopy Market by Country, 2018 - 2021, USD Million
  • TABLE 201 Europe Microscopy Market by Country, 2022 - 2028, USD Million
  • TABLE 202 Europe Cell Imaging & Analysis System Market by Country, 2018 - 2021, USD Million
  • TABLE 203 Europe Cell Imaging & Analysis System Market by Country, 2022 - 2028, USD Million
  • TABLE 204 Europe Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 205 Europe Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 206 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 207 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 208 Europe Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 209 Europe Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 210 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 211 Europe Biopharmaceutical & Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 212 Europe CROs & CMOs Market by Country, 2018 - 2021, USD Million
  • TABLE 213 Europe CROs & CMOs Market by Country, 2022 - 2028, USD Million
  • TABLE 214 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 215 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 216 Europe Diagnostic Labs Market by Country, 2018 - 2021, USD Million
  • TABLE 217 Europe Diagnostic Labs Market by Country, 2022 - 2028, USD Million
  • TABLE 218 Europe Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 219 Europe Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 220 Europe Stem Cell Research Market by Country, 2018 - 2021, USD Million
  • TABLE 221 Europe Stem Cell Research Market by Country, 2022 - 2028, USD Million
  • TABLE 222 Europe Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 223 Europe Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 224 Europe Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 225 Europe Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 226 Europe Cell Viability Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 227 Europe Cell Viability Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 228 Germany Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 229 Germany Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 230 Germany Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 231 Germany Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 232 Germany Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 233 Germany Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 234 Germany Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 235 Germany Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 236 Germany Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 237 Germany Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 238 Germany Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 239 Germany Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 240 Germany Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 241 Germany Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 242 UK Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 243 UK Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 244 UK Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 245 UK Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 246 UK Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 247 UK Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 248 UK Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 249 UK Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 250 UK Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 251 UK Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 252 UK Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 253 UK Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 254 UK Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 255 UK Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 256 France Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 257 France Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 258 France Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 259 France Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 260 France Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 261 France Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 262 France Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 263 France Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 264 France Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 265 France Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 266 France Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 267 France Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 268 France Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 269 France Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 270 Russia Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 271 Russia Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 272 Russia Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 273 Russia Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 274 Russia Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 275 Russia Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 276 Russia Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 277 Russia Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 278 Russia Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 279 Russia Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 280 Russia Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 281 Russia Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 282 Russia Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 283 Russia Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 284 Spain Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 285 Spain Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 286 Spain Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 287 Spain Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 288 Spain Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 289 Spain Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 290 Spain Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 291 Spain Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 292 Spain Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 293 Spain Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 294 Spain Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 295 Spain Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 296 Spain Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 297 Spain Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 298 Italy Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 299 Italy Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 300 Italy Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 301 Italy Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 302 Italy Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 303 Italy Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 304 Italy Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 305 Italy Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 306 Italy Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 307 Italy Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 308 Italy Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 309 Italy Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 310 Italy Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 311 Italy Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 312 Rest of Europe Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 313 Rest of Europe Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 314 Rest of Europe Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 315 Rest of Europe Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 316 Rest of Europe Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 317 Rest of Europe Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 318 Rest of Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 319 Rest of Europe Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 320 Rest of Europe Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 321 Rest of Europe Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 322 Rest of Europe Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 323 Rest of Europe Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 324 Rest of Europe Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 325 Rest of Europe Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 326 Asia Pacific Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 327 Asia Pacific Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 328 Asia Pacific Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 329 Asia Pacific Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 330 Asia Pacific Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 331 Asia Pacific Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 332 Asia Pacific Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 333 Asia Pacific Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 334 Asia Pacific Reagents & Assay Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 335 Asia Pacific Reagents & Assay Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 336 Asia Pacific Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 337 Asia Pacific Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 338 Asia Pacific Luminometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 339 Asia Pacific Luminometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 340 Asia Pacific Dye Exclusion Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 341 Asia Pacific Dye Exclusion Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 342 Asia Pacific Colorimetric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 343 Asia Pacific Colorimetric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 344 Asia Pacific Fluorometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 345 Asia Pacific Fluorometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 346 Asia Pacific Microplates Market by Country, 2018 - 2021, USD Million
  • TABLE 347 Asia Pacific Microplates Market by Country, 2022 - 2028, USD Million
  • TABLE 348 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 349 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 350 Asia Pacific Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 351 Asia Pacific Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 352 Asia Pacific Spectrophotometer Market by Country, 2018 - 2021, USD Million
  • TABLE 353 Asia Pacific Spectrophotometer Market by Country, 2022 - 2028, USD Million
  • TABLE 354 Asia Pacific Microscopy Market by Country, 2018 - 2021, USD Million
  • TABLE 355 Asia Pacific Microscopy Market by Country, 2022 - 2028, USD Million
  • TABLE 356 Asia Pacific Cell Imaging & Analysis System Market by Country, 2018 - 2021, USD Million
  • TABLE 357 Asia Pacific Cell Imaging & Analysis System Market by Country, 2022 - 2028, USD Million
  • TABLE 358 Asia Pacific Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 359 Asia Pacific Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 360 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 361 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 362 Asia Pacific Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 363 Asia Pacific Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 364 Asia Pacific Biopharmaceutical & Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 365 Asia Pacific Biopharmaceutical & Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 366 Asia Pacific CROs & CMOs Market by Country, 2018 - 2021, USD Million
  • TABLE 367 Asia Pacific CROs & CMOs Market by Country, 2022 - 2028, USD Million
  • TABLE 368 Asia Pacific Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 369 Asia Pacific Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 370 Asia Pacific Diagnostic Labs Market by Country, 2018 - 2021, USD Million
  • TABLE 371 Asia Pacific Diagnostic Labs Market by Country, 2022 - 2028, USD Million
  • TABLE 372 Asia Pacific Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 373 Asia Pacific Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 374 Asia Pacific Stem Cell Research Market by Country, 2018 - 2021, USD Million
  • TABLE 375 Asia Pacific Stem Cell Research Market by Country, 2022 - 2028, USD Million
  • TABLE 376 Asia Pacific Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 377 Asia Pacific Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 378 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 379 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 380 Asia Pacific Cell Viability Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 381 Asia Pacific Cell Viability Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 382 China Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 383 China Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 384 China Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 385 China Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 386 China Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 387 China Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 388 China Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 389 China Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 390 China Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 391 China Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 392 China Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 393 China Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 394 China Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 395 China Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 396 Japan Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 397 Japan Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 398 Japan Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 399 Japan Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 400 Japan Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 401 Japan Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 402 Japan Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 403 Japan Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 404 Japan Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 405 Japan Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 406 Japan Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 407 Japan Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 408 Japan Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 409 Japan Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 410 India Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 411 India Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 412 India Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 413 India Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 414 India Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 415 India Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 416 India Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 417 India Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 418 India Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 419 India Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 420 India Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 421 India Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 422 India Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 423 India Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 424 South Korea Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 425 South Korea Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 426 South Korea Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 427 South Korea Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 428 South Korea Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 429 South Korea Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 430 South Korea Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 431 South Korea Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 432 South Korea Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 433 South Korea Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 434 South Korea Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 435 South Korea Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 436 South Korea Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 437 South Korea Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 438 Singapore Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 439 Singapore Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 440 Singapore Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 441 Singapore Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 442 Singapore Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 443 Singapore Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 444 Singapore Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 445 Singapore Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 446 Singapore Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 447 Singapore Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 448 Singapore Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 449 Singapore Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 450 Singapore Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 451 Singapore Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 452 Malaysia Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 453 Malaysia Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 454 Malaysia Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 455 Malaysia Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 456 Malaysia Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 457 Malaysia Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 458 Malaysia Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 459 Malaysia Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 460 Malaysia Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 461 Malaysia Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 462 Malaysia Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 463 Malaysia Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 464 Malaysia Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 465 Malaysia Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 466 Rest of Asia Pacific Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 467 Rest of Asia Pacific Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 468 Rest of Asia Pacific Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 469 Rest of Asia Pacific Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 470 Rest of Asia Pacific Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 471 Rest of Asia Pacific Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 472 Rest of Asia Pacific Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 473 Rest of Asia Pacific Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 474 Rest of Asia Pacific Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 475 Rest of Asia Pacific Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 476 Rest of Asia Pacific Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 477 Rest of Asia Pacific Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 478 Rest of Asia Pacific Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 479 Rest of Asia Pacific Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 480 LAMEA Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 481 LAMEA Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 482 LAMEA Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 483 LAMEA Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 484 LAMEA Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 485 LAMEA Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 486 LAMEA Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 487 LAMEA Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 488 LAMEA Reagents & Assay Kits Market by Country, 2018 - 2021, USD Million
  • TABLE 489 LAMEA Reagents & Assay Kits Market by Country, 2022 - 2028, USD Million
  • TABLE 490 LAMEA Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 491 LAMEA Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 492 LAMEA Luminometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 493 LAMEA Luminometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 494 LAMEA Dye Exclusion Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 495 LAMEA Dye Exclusion Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 496 LAMEA Colorimetric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 497 LAMEA Colorimetric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 498 LAMEA Fluorometric Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 499 LAMEA Fluorometric Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 500 LAMEA Microplates Market by Country, 2018 - 2021, USD Million
  • TABLE 501 LAMEA Microplates Market by Country, 2022 - 2028, USD Million
  • TABLE 502 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 503 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 504 LAMEA Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 505 LAMEA Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 506 LAMEA Spectrophotometer Market by Country, 2018 - 2021, USD Million
  • TABLE 507 LAMEA Spectrophotometer Market by Country, 2022 - 2028, USD Million
  • TABLE 508 LAMEA Microscopy Market by Country, 2018 - 2021, USD Million
  • TABLE 509 LAMEA Microscopy Market by Country, 2022 - 2028, USD Million
  • TABLE 510 LAMEA Cell Imaging & Analysis System Market by Country, 2018 - 2021, USD Million
  • TABLE 511 LAMEA Cell Imaging & Analysis System Market by Country, 2022 - 2028, USD Million
  • TABLE 512 LAMEA Flow Cytometry Market by Country, 2018 - 2021, USD Million
  • TABLE 513 LAMEA Flow Cytometry Market by Country, 2022 - 2028, USD Million
  • TABLE 514 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 515 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 516 LAMEA Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 517 LAMEA Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 518 LAMEA Biopharmaceutical & Pharmaceutical Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 519 LAMEA Biopharmaceutical & Pharmaceutical Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 520 LAMEA CROs & CMOs Market by Country, 2018 - 2021, USD Million
  • TABLE 521 LAMEA CROs & CMOs Market by Country, 2022 - 2028, USD Million
  • TABLE 522 LAMEA Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 523 LAMEA Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 524 LAMEA Diagnostic Labs Market by Country, 2018 - 2021, USD Million
  • TABLE 525 LAMEA Diagnostic Labs Market by Country, 2022 - 2028, USD Million
  • TABLE 526 LAMEA Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 527 LAMEA Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 528 LAMEA Stem Cell Research Market by Country, 2018 - 2021, USD Million
  • TABLE 529 LAMEA Stem Cell Research Market by Country, 2022 - 2028, USD Million
  • TABLE 530 LAMEA Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 531 LAMEA Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 532 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 533 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 534 LAMEA Cell Viability Assays Market by Country, 2018 - 2021, USD Million
  • TABLE 535 LAMEA Cell Viability Assays Market by Country, 2022 - 2028, USD Million
  • TABLE 536 Brazil Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 537 Brazil Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 538 Brazil Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 539 Brazil Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 540 Brazil Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 541 Brazil Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 542 Brazil Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 543 Brazil Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 544 Brazil Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 545 Brazil Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 546 Brazil Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 547 Brazil Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 548 Brazil Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 549 Brazil Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 550 Argentina Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 551 Argentina Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 552 Argentina Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 553 Argentina Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 554 Argentina Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 555 Argentina Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 556 Argentina Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 557 Argentina Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 558 Argentina Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 559 Argentina Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 560 Argentina Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 561 Argentina Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 562 Argentina Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 563 Argentina Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 564 UAE Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 565 UAE Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 566 UAE Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 567 UAE Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 568 UAE Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 569 UAE Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 570 UAE Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 571 UAE Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 572 UAE Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 573 UAE Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 574 UAE Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 575 UAE Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 576 UAE Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 577 UAE Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 578 Saudi Arabia Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 579 Saudi Arabia Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 580 Saudi Arabia Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 581 Saudi Arabia Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 582 Saudi Arabia Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 583 Saudi Arabia Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 584 Saudi Arabia Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 585 Saudi Arabia Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 586 Saudi Arabia Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 587 Saudi Arabia Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 588 Saudi Arabia Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 589 Saudi Arabia Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 590 Saudi Arabia Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 591 Saudi Arabia Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 592 South Africa Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 593 South Africa Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 594 South Africa Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 595 South Africa Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 596 South Africa Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 597 South Africa Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 598 South Africa Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 599 South Africa Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 600 South Africa Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 601 South Africa Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 602 South Africa Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 603 South Africa Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 604 South Africa Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 605 South Africa Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 606 Nigeria Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 607 Nigeria Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 608 Nigeria Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 609 Nigeria Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 610 Nigeria Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 611 Nigeria Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 612 Nigeria Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 613 Nigeria Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 614 Nigeria Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 615 Nigeria Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 616 Nigeria Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 617 Nigeria Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 618 Nigeria Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 619 Nigeria Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 620 Rest of LAMEA Cell Viability Assays Market, 2018 - 2021, USD Million
  • TABLE 621 Rest of LAMEA Cell Viability Assays Market, 2022 - 2028, USD Million
  • TABLE 622 Rest of LAMEA Cell Viability Assays Market by Product, 2018 - 2021, USD Million
  • TABLE 623 Rest of LAMEA Cell Viability Assays Market by Product, 2022 - 2028, USD Million
  • TABLE 624 Rest of LAMEA Cell Viability Assays Market by Consumables Type, 2018 - 2021, USD Million
  • TABLE 625 Rest of LAMEA Cell Viability Assays Market by Consumables Type, 2022 - 2028, USD Million
  • TABLE 626 Rest of LAMEA Cell Viability Assays Market by Reagents & Assay Kits Type, 2018 - 2021, USD Million
  • TABLE 627 Rest of LAMEA Cell Viability Assays Market by Reagents & Assay Kits Type, 2022 - 2028, USD Million
  • TABLE 628 Rest of LAMEA Cell Viability Assays Market by Instruments Type, 2018 - 2021, USD Million
  • TABLE 629 Rest of LAMEA Cell Viability Assays Market by Instruments Type, 2022 - 2028, USD Million
  • TABLE 630 Rest of LAMEA Cell Viability Assays Market by End-user, 2018 - 2021, USD Million
  • TABLE 631 Rest of LAMEA Cell Viability Assays Market by End-user, 2022 - 2028, USD Million
  • TABLE 632 Rest of LAMEA Cell Viability Assays Market by Application, 2018 - 2021, USD Million
  • TABLE 633 Rest of LAMEA Cell Viability Assays Market by Application, 2022 - 2028, USD Million
  • TABLE 634 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 635 key Information - Agilent Technologies, Inc.
  • TABLE 636 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 637 Key information - Becton, Dickinson and Company
  • TABLE 638 key Information - PerkinElmer, Inc.
  • TABLE 639 key Information - Merck KGaA
  • TABLE 640 key information - Abcam plc
  • TABLE 641 key Information - Promega Corporation
  • TABLE 642 Key Information - Creative Bioarray
  • TABLE 643 Key Information - Biotium, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Global Cell Viability Assays Market share by Product, 2021
  • FIG 5 Global Cell Viability Assays Market share by Product, 2028
  • FIG 6 Global Cell Viability Assays Market by Product, 2018 - 2028, USD Million
  • FIG 7 Global Cell Viability Assays Market share by End-user, 2021
  • FIG 8 Global Cell Viability Assays Market share by End-user, 2028
  • FIG 9 Global Cell Viability Assays Market by End-user, 2018 - 2028, USD Million
  • FIG 10 Global Cell Viability Assays Market share by Application, 2021
  • FIG 11 Global Cell Viability Assays Market share by Application, 2028
  • FIG 12 Global Cell Viability Assays Market by Application, 2018 - 2028, USD Million
  • FIG 13 Global Cell Viability Assays Market share by Region, 2021
  • FIG 14 Global Cell Viability Assays Market share by Region, 2028
  • FIG 15 Global Cell Viability Assays Market by Region, 2018 - 2028, USD Million
  • FIG 16 Recent strategies and developments: Thermo Fisher Scientific Inc.
  • FIG 17 Recent strategies and developments: Becton, Dickinson and Company